Style | Citing Format |
---|---|
MLA | Alinejad M, et al.. "Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications." Journal of Cancer Research and Therapeutics, vol. 16, no. 4, 2020, pp. 878-883. |
APA | Alinejad M, Pourmoghaddas A, Amouheidari A, Shokrani P (2020). Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications. Journal of Cancer Research and Therapeutics, 16(4), 878-883. |
Chicago | Alinejad M, Pourmoghaddas A, Amouheidari A, Shokrani P. "Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications." Journal of Cancer Research and Therapeutics 16, no. 4 (2020): 878-883. |
Harvard | Alinejad M et al. (2020) 'Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications', Journal of Cancer Research and Therapeutics, 16(4), pp. 878-883. |
Vancouver | Alinejad M, Pourmoghaddas A, Amouheidari A, Shokrani P. Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications. Journal of Cancer Research and Therapeutics. 2020;16(4):878-883. |
BibTex | @article{ author = {Alinejad M and Pourmoghaddas A and Amouheidari A and Shokrani P}, title = {Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications}, journal = {Journal of Cancer Research and Therapeutics}, volume = {16}, number = {4}, pages = {878-883}, year = {2020} } |
RIS | TY - JOUR AU - Alinejad M AU - Pourmoghaddas A AU - Amouheidari A AU - Shokrani P TI - Improvement of Metallic Artifacts in Computed Tomography in the Absence of Artifact Reduction Algorithms for Spinal Treatment Planning Applications JO - Journal of Cancer Research and Therapeutics VL - 16 IS - 4 SP - 878 EP - 883 PY - 2020 ER - |